514 related articles for article (PubMed ID: 28069569)
1. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
[TBL] [Abstract][Full Text] [Related]
2. CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.
Jiang Y; Ortega-Molina A; Geng H; Ying HY; Hatzi K; Parsa S; McNally D; Wang L; Doane AS; Agirre X; Teater M; Meydan C; Li Z; Poloway D; Wang S; Ennishi D; Scott DW; Stengel KR; Kranz JE; Holson E; Sharma S; Young JW; Chu CS; Roeder RG; Shaknovich R; Hiebert SW; Gascoyne RD; Tam W; Elemento O; Wendel HG; Melnick AM
Cancer Discov; 2017 Jan; 7(1):38-53. PubMed ID: 27733359
[TBL] [Abstract][Full Text] [Related]
3. KMT2D acetylation by CREBBP reveals a cooperative functional interaction at enhancers in normal and malignant germinal center B cells.
Vlasevska S; Garcia-Ibanez L; Duval R; Holmes AB; Jahan R; Cai B; Kim A; Mo T; Basso K; Soni RK; Bhagat G; Dalla-Favera R; Pasqualucci L
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2218330120. PubMed ID: 36893259
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.
Hashwah H; Schmid CA; Kasser S; Bertram K; Stelling A; Manz MG; Müller A
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9701-9706. PubMed ID: 28831000
[TBL] [Abstract][Full Text] [Related]
5.
García-Ramírez I; Tadros S; González-Herrero I; Martín-Lorenzo A; Rodríguez-Hernández G; Moore D; Ruiz-Roca L; Blanco O; Alonso-López D; Rivas JL; Hartert K; Duval R; Klinkebiel D; Bast M; Vose J; Lunning M; Fu K; Greiner T; Rodrigues-Lima F; Jiménez R; Criado FJG; Cenador MBG; Brindle P; Vicente-Dueñas C; Alizadeh A; Sánchez-García I; Green MR
Blood; 2017 May; 129(19):2645-2656. PubMed ID: 28288979
[TBL] [Abstract][Full Text] [Related]
6. TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.
Dominguez PM; Ghamlouch H; Rosikiewicz W; Kumar P; Béguelin W; Fontán L; Rivas MA; Pawlikowska P; Armand M; Mouly E; Torres-Martin M; Doane AS; Calvo Fernandez MT; Durant M; Della-Valle V; Teater M; Cimmino L; Droin N; Tadros S; Motanagh S; Shih AH; Rubin MA; Tam W; Aifantis I; Levine RL; Elemento O; Inghirami G; Green MR; Figueroa ME; Bernard OA; Aoufouchi S; Li S; Shaknovich R; Melnick AM
Cancer Discov; 2018 Dec; 8(12):1632-1653. PubMed ID: 30274972
[No Abstract] [Full Text] [Related]
7. Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma.
Meyer SN; Scuoppo C; Vlasevska S; Bal E; Holmes AB; Holloman M; Garcia-Ibanez L; Nataraj S; Duval R; Vantrimpont T; Basso K; Brooks N; Dalla-Favera R; Pasqualucci L
Immunity; 2019 Sep; 51(3):535-547.e9. PubMed ID: 31519498
[TBL] [Abstract][Full Text] [Related]
8. Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes.
Rivas MA; Durmaz C; Kloetgen A; Chin CR; Chen Z; Bhinder B; Koren A; Viny AD; Scharer CD; Boss JM; Elemento O; Mason CE; Melnick AM
Front Immunol; 2021; 12():688493. PubMed ID: 34621263
[TBL] [Abstract][Full Text] [Related]
9. Inactivating mutations of acetyltransferase genes in B-cell lymphoma.
Pasqualucci L; Dominguez-Sola D; Chiarenza A; Fabbri G; Grunn A; Trifonov V; Kasper LH; Lerach S; Tang H; Ma J; Rossi D; Chadburn A; Murty VV; Mullighan CG; Gaidano G; Rabadan R; Brindle PK; Dalla-Favera R
Nature; 2011 Mar; 471(7337):189-95. PubMed ID: 21390126
[TBL] [Abstract][Full Text] [Related]
10. Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma.
Desmots F; Roussel M; Pangault C; Llamas-Gutierrez F; Pastoret C; Guiheneuf E; Le Priol J; Camara-Clayette V; Caron G; Henry C; Belaud-Rotureau MA; Godmer P; Lamy T; Jardin F; Tarte K; Ribrag V; Fest T
Clin Cancer Res; 2019 Jan; 25(2):735-746. PubMed ID: 30348636
[TBL] [Abstract][Full Text] [Related]
11. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
Rivas MA; Meydan C; Chin CR; Challman MF; Kim D; Bhinder B; Kloetgen A; Viny AD; Teater MR; McNally DR; Doane AS; Béguelin W; Fernández MTC; Shen H; Wang X; Levine RL; Chen Z; Tsirigos A; Elemento O; Mason CE; Melnick AM
Nat Immunol; 2021 Feb; 22(2):240-253. PubMed ID: 33432228
[TBL] [Abstract][Full Text] [Related]
12. Targeting HDAC3 in CREBBP-Mutant Lymphomas Counterstrikes Unopposed Enhancer Deacetylation of B-cell Signaling and Immune Response Genes.
Höpken UE
Cancer Discov; 2017 Jan; 7(1):14-16. PubMed ID: 28062671
[TBL] [Abstract][Full Text] [Related]
13. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.
Cattoretti G; Pasqualucci L; Ballon G; Tam W; Nandula SV; Shen Q; Mo T; Murty VV; Dalla-Favera R
Cancer Cell; 2005 May; 7(5):445-55. PubMed ID: 15894265
[TBL] [Abstract][Full Text] [Related]
14. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
Front Immunol; 2021; 12():683597. PubMed ID: 34335584
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
16. The many layers of epigenetic dysfunction in B-cell lymphomas.
Jiang Y; Dominguez PM; Melnick AM
Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
[TBL] [Abstract][Full Text] [Related]
17. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
Seifert M; Küppers R
Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
[TBL] [Abstract][Full Text] [Related]
18. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
19. Exploration of factors affecting the onset and maturation course of follicular lymphoma through simulations of the germinal center.
Fenwick MK; Escobedo FA
Bull Math Biol; 2009 Aug; 71(6):1432-62. PubMed ID: 19412639
[TBL] [Abstract][Full Text] [Related]
20. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.
Zhang J; Dominguez-Sola D; Hussein S; Lee JE; Holmes AB; Bansal M; Vlasevska S; Mo T; Tang H; Basso K; Ge K; Dalla-Favera R; Pasqualucci L
Nat Med; 2015 Oct; 21(10):1190-8. PubMed ID: 26366712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
